TOPTimes of India ยท 1 day agoLive
Biosimilar drugs breaking high-cost barrier to cancer immunotherapy
Reported by Times of India, not nibnow. We are not the publisher of this story, only the source is.
No additional analysis available for this story yet.
WHAT HAPPENED
Recent changes in cancer care in India show an increase in immunotherapy prescriptions due to affordable biosimilars. Doctors report that the availability of cheaper versions of nivolumab has improved patient access to treatment. Research indicates that lower doses may be effective for Indian patients, contributing to the affordability of therapy. Although progress has been made, significant challenges remain regarding drug availability and hospital practices.
Text size
READ IN YOUR LENS
UPSCMarketsFounder